Filtros de búsqueda

Lista de obras de

"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer.

artículo científico publicado en 2010

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

artículo científico publicado en 2017

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

artículo científico publicado en 2013

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

artículo científico publicado en 2007

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

artículo científico publicado en 2013

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

artículo científico publicado en 2010

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

artículo científico publicado en 2003

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

artículo científico publicado en 2012

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

artículo científico publicado en 2016

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

scientific article published on 16 October 2019

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

artículo científico publicado en 2015

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

scientific article published on 26 November 2018

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

artículo científico publicado en 2016

Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma

artículo científico publicado en 2007

Adjuvant chemotherapy in breast cancer: back to the future.

artículo científico publicado en 2003

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

artículo científico publicado en 2008

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

artículo científico publicado en 2003

Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issues.

artículo científico publicado en 2010

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

artículo científico publicado en 2014

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

artículo científico publicado en 2007

Adjuvant ovarian suppression in premenopausal breast cancer

artículo científico publicado en 2014

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial

artículo científico publicado en 2013

Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapy.

artículo científico publicado en 2003

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

artículo científico

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.

artículo científico publicado en 2013

Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

artículo científico publicado en 2010

Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI

scientific article published on 18 May 2007

An interview with Dr. Aron Goldhirsch

artículo científico publicado en 2002

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

artículo científico publicado en 2011

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

artículo científico publicado en 2007

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

artículo científico publicado en 2016

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

artículo científico publicado en 2015

Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?

artículo científico publicado en 2012

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

artículo científico publicado en 2011

Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence?

artículo científico publicado en 2011

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

artículo científico publicado en 2018

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013

Best management of locally advanced inoperable breast cancer

artículo científico publicado en 2013

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

artículo científico publicado en 2014

Biopsy of liver metastasis for women with breast cancer: Impact on survival

article by Edoardo Botteri et al published June 2012 in The Breast

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

artículo científico publicado en 2014

Breast cancer in the elderly.

artículo científico publicado en 2007

Breast cancer in young women: climbing for progress in care and knowledge

artículo científico publicado en 2006

Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy

scientific article published on 04 September 2012

Breast cancer: why do women opt for contralateral prophylactic mastectomy?

scientific article published on 08 July 2014

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis

artículo científico

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

artículo científico publicado en 2015

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

artículo científico publicado en 2012

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

article

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

artículo científico publicado en 2010

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

artículo científico publicado en 2007

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

artículo científico publicado en 2010

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

artículo científico publicado en 2008

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

artículo científico publicado en 2017

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

artículo científico publicado en 2010

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

scientific article published on 08 December 2020

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

artículo científico publicado en 2010

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

artículo científico publicado en 2010

Comparing Treatments Using Quality-Adjusted Survival: The Q-TWiST Method

Comparing aromatase inhibitors in the absence of clinical trial results can be misleading

artículo científico publicado en 2007

Conservative surgery in patients with multifocal/multicentric breast cancer

artículo científico publicado en 2008

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

artículo científico publicado en 2020

Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment

artículo científico publicado en 2014

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

artículo científico publicado en 2020

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results

artículo científico publicado en 2003

Dendritic cell-based vaccines: clinical applications in breast cancer.

artículo científico

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

artículo científico publicado en 2013

Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system

scientific article published on 27 July 2018

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

artículo científico publicado en 2013

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials

artículo científico publicado en 2008

Do Early Breast Cancer Patients with Only Sentinel Lymph Node Biopsy Experience Lower Psychological Morbidity Over Time? ⬇️

artículo científico publicado el 11 de octubre de 2012

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

artículo científico publicado en 2014

Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.

artículo científico publicado en 2007

Drug-induced immune thrombocytopenia

artículo científico publicado en 2007

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

artículo científico publicado en 2015

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93

scientific article published on 11 April 2007

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

artículo científico publicado en 2019

Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series

artículo científico publicado en 2014

Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy

scientific article published on 01 March 2020

Exemestane seems to stimulate tumour growth in men with prostate carcinoma

artículo científico publicado en 2003

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2017

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

artículo científico publicado en 2015

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care.

artículo científico publicado en 2016

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

artículo científico publicado en 2020

HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence

artículo científico publicado en 2016

HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17

scientific article published on 12 September 2007

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

artículo científico publicado en 2012

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.

artículo científico publicado en 2013

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

artículo científico publicado en 2011

Immune approaches to the treatment of breast cancer, around the corner?

artículo científico publicado en 2014

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

artículo científico publicado en 2014

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

artículo científico publicado en 2011

Immunohistochemically defined subtypes and outcome of apocrine breast cancer

artículo científico publicado en 2012

Immunology and breast cancer: therapeutic cancer vaccines.

artículo científico publicado en 2007

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

artículo científico publicado en 2016

Impact of autoimmune diseases on outcome of patients with early breast cancer.

artículo científico publicado en 2016

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

artículo científico publicado en 2015

Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study

artículo científico publicado en 2015

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab ⬇️

artículo científico publicado el 16 de febrero de 2012

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

artículo científico publicado en 2008

Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study

artículo científico publicado en 2015

Intrathecal chemotherapy in carcinomatous meningitis from breast cancer

artículo científico publicado en 2002

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

artículo científico publicado en 2008

Invasive lobular breast cancer: subtypes and outcome

artículo científico publicado en 2012

Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer? ⬇️

artículo científico publicado el 21 de febrero de 2012

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

artículo científico publicado en 2008

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

artículo científico publicado en 2008

Keeping faith with trial volunteers

artículo científico publicado en 2007

Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?

artículo científico publicado en 2003

Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

artículo científico publicado en 2012

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

artículo científico publicado en 2008

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.

artículo científico publicado en 2011

Locoregional recurrence in patients with HER2 positive breast cancer

artículo científico publicado en 2013

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

artículo científico publicado en 2019

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

artículo científico publicado en 2016

Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter

artículo científico publicado en 2007

Mediastinal lymphoadenopathy in a patient with breast cancer

artículo científico publicado en 2002

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

artículo científico publicado en 2003

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity

artículo científico publicado en 2012

Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?

artículo científico publicado en 2009

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

artículo científico publicado en 2008

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

artículo científico publicado en 2009

Molecular pathways: human leukocyte antigen G (HLA-G).

artículo científico

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

artículo científico publicado en 2013

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

artículo científico publicado en 2018

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

scientific article published on 27 December 2018

Neoadjuvant chemotherapy for breast cancer: any progress?

artículo científico publicado en 2013

Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?

artículo científico publicado en 2010

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

artículo científico publicado en 2010

New criteria for selecting elderly patients for breast cancer adjuvant treatment studies

artículo científico publicado en 2007

No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysis

artículo científico publicado en 2013

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

artículo científico publicado en 2012

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

artículo científico publicado en 2012

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

artículo científico publicado en 2015

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

artículo científico publicado en 2015

Outcome of male breast cancer: a matched single-institution series

artículo científico publicado en 2014

Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.

artículo científico publicado en 2013

Overhauling the breast cancer overview: are subsets subversive?

artículo científico publicado en 2002

Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice.

artículo científico publicado en 2008

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

scientific article published on 18 July 2007

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

artículo científico publicado en 2010

Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?

artículo científico publicado en 2013

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

artículo científico publicado en 2015

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

artículo científico publicado en 2013

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

artículo científico publicado en 2009

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

artículo científico publicado en 2011

Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient

artículo científico

Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer

artículo científico publicado en 2015

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

artículo científico publicado en 2002

Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.

artículo científico publicado en 2010

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial

artículo científico publicado en 2018

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.

artículo científico publicado en 2015

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

artículo científico publicado en 2008

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

artículo científico publicado en 2015

Pregnancy after breast cancer: if you wish, ma’am ⬇️

artículo científico publicado el 23 de junio de 2011

Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors

artículo científico publicado en 2008

Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer

artículo científico publicado en 2010

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

artículo científico publicado en 2018

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

artículo científico publicado en 2008

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

artículo científico publicado en 2007

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

artículo científico publicado en 2012

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX ⬇️

artículo científico publicado el 5 de noviembre de 2012

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

artículo científico publicado en 2012

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

artículo científico publicado en 2014

QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.

artículo científico

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

artículo científico publicado en 2019

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

artículo científico publicado en 2013

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

artículo científico publicado en 2007

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

artículo científico publicado en 2015

Reply to Jeffrey Graham, Omar Abdel-Rahman, Toni K. Choueiri, and Daniel Y.C. Heng's Letter to the Editor re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysi

scientific article published on 14 September 2018

Reply to L. Moscetti

artículo científico publicado en 2017

Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulin

artículo científico publicado en 2016

Results of chest wall resection for recurrent or locally advanced breast malignancies.

artículo científico publicado en 2007

Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases.

artículo científico publicado en 2013

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy

artículo científico publicado en 2008

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.

artículo científico publicado en 2017

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group

artículo científico publicado en 2008

Sentinel lymph node biopsy in pregnant patients with breast cancer

artículo científico publicado en 2010

Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome

scientific article published on 28 December 2018

Sex as a predictor of response to cancer immunotherapy - Authors' reply

scientific article published on 01 August 2018

Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis

artículo científico publicado en 2019

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

artículo científico publicado en 2013

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

artículo científico publicado en 2007

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

artículo científico publicado en 2018

Targeting the subtypes of breast cancer: rethinking investigational drugs

artículo científico

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

artículo científico publicado en 2011

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

artículo científico publicado en 2011

The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study

scientific article published on 16 December 2011

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy

article

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer

scientific article published on 09 April 2007

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

artículo científico publicado en 2013

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

artículo científico publicado en 2016

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

artículo científico publicado en 2016

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy

scientific article published on 20 March 2010

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

artículo científico publicado en 2010

To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancer

artículo científico publicado en 2007

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

article

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

artículo científico publicado en 2005

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

artículo científico publicado en 2015

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

artículo científico publicado en 2016

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

artículo científico publicado en 2017

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

artículo científico publicado en 2011

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

artículo científico publicado en 2016

Vaccine immunotherapy in breast cancer treatment: promising, but still early.

artículo científico publicado en 2007

Weekly epirubicin in the treatment of gestational breast cancer (GBC).

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda